藥物成份
共有 21645 個藥物成份
(1)Solid Phase 20.0 ml containing Streptavidin-coated paramagnetic microparticles preformed with biotinylated HIV antigens (~1.0μg/mL) in buffer with bovine serum albumin, goat serum, surfactant, and preservatives.\n(2)Lite Reagent 10.0 ml containing recombinant HIV antigens, labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(3)Ancillary Lite Reagent 10.0 ml containing recombinant HIV antigens labeled with acridinium ester in buffer with bovine serum albumin, mouse lgG, goat serum, surfactant, and preservatives.\n(4)EHIV calibrator vials: 2.0 ml/vial processed human plasma negative for antibodies toHIV spiked with antibodies to HIV-1, sodium azide (<0.1%) and preservatives.\n\nEHIV quality control material containing 7.0 ml/vial processed human plasma nonreactive for HIV, reactive for HIV-1, and reactive for HIV-2 with preservatives.
(Chloral Hydrate), (Ethylene Glycol, acetic acid 99-100%), (Purified water, Sodium iodide, Aluminium Sulfate, Propyleneglycol), (Ethanol, methanol), (wasser), (Ethylene Glycol, acetic acid 99-100%), (Ethanol, methanol), (Ethanol, methanol), (Ethanol, methanol, acetic acid, 99-100%)
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles, 0.72 mg/mL; binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-digoxin-Ab~Ru(bpy)32+ (gray cap), 1 bottle, 10ml: Monoclonal anti-digoxin antibody (mouse) labeled with ruthenium complex 15 μg/L; monoclonal anti-digoxin antibody (mouse) 5mg/L, phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Digoxin-dervative~biotin (black cap), 1 bottle, 10ml: Biotinylated digoxigenin 1.06 ng/ml; biotin 15μg/L; phosphate buffer 100 mmol/L, pH 7.0 ; preservative.(CalSet)DIGO Cal1: 2 bottles, each for 1.5mL of calibrator 1DIGO Cal2: 2 bottles, each for 1.5mL of calibrator 2Digoxin in two concentration ranges (approx. 0.61 ng/mL or 0.78 nmol/L and approx. 3.61 ng/mL or 4.62 nmol/L) in a buffer/protein (bovine serum) matrix.
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 ml:Streptavidin-coated microparticles, 0.72 mg/mL, binding capacity: 470 ng biotin/mg microparticles; preservative.R1 Anti-CK-MB-Ab~biotin(gray cap), 1 bottle, 10 ml: Biotinylated monoclonal anti-CK-MB antibody(mouse)1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+(black cap),1 bottle, 10mL:Monoclonal anti-CK-MB antibody (mouse) labeled with ruthenium complex 1.2 mg/L; phosphate buffer 100 mmol/L, pH 7.0; preservative.(CalSet)CK-MB STAT Cal1:2 bottles, each for 1.0mL of calibrator 1CK-MB STAT Cal2:2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5ng/mL and approx.25ng/mL) in a human serum matrix.
(Reagent)M Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5mL：Streptavidin-coated microparticles, 0.72mg/mL； binding capacity：470 ng biotin/mg microparticles； preservative.R1 Anti-CK-MB-Ab~biotin (gray cap), 1 bottle, 10ml： Biotinylated monoclonal anti-CK-MB antibody (mouse) 1.2mg/L； Phosphate buffer 100 mmol/L, pH 7.0； preservative.R2 Anti-CK-MB~Ab~Ru(bpy)32+ (black cap), 1 bottle, 10ml： Monoclonal anti-CK-MB-antibody (mouse) labeled with ruthenium complex 1.2mg/L; phosphate buffer 100 mmol/L, pH 7.0； preservative.(CalSet)CK-MB Cal1：2 bottles, each for 1.0mL of calibrator 1CK-MB Cal2：2 bottles, each for 1.0mL of calibrator 2CK-MB (human) in two concentration ranges (approx. 1.5 ng/mL and 25 ng/mL) in a human serum matrix.
(ug/mL) Amikacin (8-32), Amoxicillin/Clavulanate(4/2-16/8), Ampicillin(4-16), Aztreonam(2-16), Cefazolin(4-16), Cefotaxime(4-32), Cefoxitin(4-16), Ceftazidime(1-16), Cefuroxime(4-16), Cephalothin(4-16), Ciprofloxacin(0.5-2), Gentamicin(2-8), Imipenem(1-8), Levofloxacin(1-4), Meropenem(1-8), Moxifloxacin(1-4), Nitrofurantoin(16-64), Piperacillin(4-64), Piperacillin/Tazobactam(4/4-64/4), Ticarcillin/Clavulanic Acid(8/2-64/2), Tobramycin(2-8), Trimethoprim/Sulfamethoxazole(0.5/9.5-2/38), ESBL Cefotaxime/Clavulanate(<9), Ceftazidime/Clavulanate(ESBL)(<9), Cefpodoxime-proxetil (ESBL)(<9), Ceftazidime(ESBL)(<9), Ceftriaxone/Clavulanate(ESBL)(<9)
*30 CK-MB Strips：\nSerum diluent：Tris-NaCl (0.05 mol/l, pH 7.4), protein and chemical stabilizers, 0.9 g/l sodium azide (300 μl).\nWash buffer：Tris-NaCl (0.05 mol/l, pH 7.4), protein stabilizers, 0.9 g/l sodium azide (600 μl).\nWash buffer：Tris-NaCl (0.05 mol/l, pH 7.4), surfactant, 0.9 g/l sodium azide (600 μl).\nConjugate：alkaline phosphatase labeled anti-CK-MM polyclonal antibody Fab’fragment (goat), Tris-NaCl (0.05 mol/l, pH 6), protein stabilizers, 0.9 g/l sodium azide (400 μl).\nCuvette with substrate：4-Methyl-umbelliferyl phosphate (0.6 mmol/l) + diethanolamine(DEA*) (0.62 mol/l or 6.6%, pH 9.2) + 1 g/l sodium azdie (300 μl).\n*30 CK-MB SPRs：\nInterior of SPRs coated with monoclonal anti-CK-MB immunoglobulins (mouse).\n*CK-MB Control：1 × 3 mL\nProtein base (BSA) + chemical stabilizers + human CK-MB.\n*CK-MB Calibrator：1 × 3 mL\nProtein base (BSA) + chemical stabilizers + human CK-MB.\nReconstitution solvent：1 × 20 mL\nDemineralized water + 0.9 g/l sodium azide.\n*MLE card
.HAV IgM ReadyPack includes :\n(1) Lite Reagent 5.0 ml containing Monoclonal antibody (F(ab)2 fragment; ~0.3 μg/ml) labeled with acridinium ester in buffer with bovine serum albumin, surfactant, sodium azide (<0.1%) and preservatives.\n(2) Solid phase 15.0 ml containing streptavidin coated paramagnetic microparticles in buffer with bovine serum albumin, surfactant, sodium azide (<0.1%) and preservatives.\n(3) Antigen well reagent 5.0 ml containing inactivated hepatitis A virus (<0.1 μg/ml) in buffer with bovine serum albumin, surfactant, sodium azide (<0.1%), and preservatives. \n(4) Ancillary Reagent 25.0 ml containing biotinylated monoclonal mouse anti-human IgM (~0.500 μg/ml) in buffer with bovine serum albumin, mouse IgG, surfactant, sodium azide (<0.1%), and preservatives. \n(5) HAV IgM calibrator vials: 2.0 ml/vial processed human plasma positive for IgM antibodies to HAV with preservatives.\n.HAV IgM quality control material 7.0 ml/via containing l processed human plasma negative and positive for \nIg
.Murine Monoclonal Anti β-HCG-coated microtiter wells.\n.Set of Reference Standards: 0, 2.5, 5, 10, 25, and 50 ng/ml, lyophilized.\n.Zero Buffer (Sample diluent), 13 ml.\n.Enzyme Conjugate Reagent, 18 ml.\n.TMB Reagent (One-Step), 11 ml.\n.Stop Solution (1N HCl), 11 ml.
0.003% cardiolipin, 0.020-0.022% lecithin, 0.09% cholesterol, 0.0125 M EDTA, 0.01 M Na2HPO4, 0.01 M KH2PO4, 0.1% thimerosal (preservative), 0.02% charcoal (specially prepared, Becton Dickinson), 10% choline chloride w/v, deionzed/distilled water*.
0.003% cardiolipin, 0.020-0.022% lecithin, 0.09% cholesterol, 0.0125 M EDTA, 0.01 M Na2HPO4, 0.01 M KH2PO4, 0.1% thimerosal (preservative), 0.02% charcoal (specially prepared, Becton Dickinson), 10% choline chloride, w/v, and deionzed/distilled water.
0.025 mg Sodium citrate, 0.013 mg Gold chloride, 0.2 μg Mouse anti β-HCG, 0.12 μg Mouse IgG, 0.6 μg Goat anti mouse IgG, 0.6 μg Goat anti α-HCG, 9 mg Sodium chloride, 0.278 mg Sodium phosphate, Monobasic Crystal, 1.38 mg (Sodium Phosphate, Dibasic, Anhydrous), 2 mg NaN3, 0.02 g BSA.
0.025 mg Sodium citrate, 0.013 mg Gold chloride, 0.2 μg Mouse anti β-HCG, 0.12 μg Mouse IgG, 0.6 μg Goat anti mouse IgG, 0.6 μg Goat anti α-HCG, 9 mg Sodium chloride, 0.278 mg Sodium phosphate, Monobasic Crystal, 1.38 mg Sodium Phosphate, Dibasic, Anhydrous, 2 mg NaN3, 0.02 g BSA
0.025 mg Sodium citrate, 0.013 mg Gold chloride, 0.2μg Mouse antiβ-HCG, 0.12μg Mouse IgG,0.6μg Goat anti mouse IgG, 0.6μg Goat antiα-HCG, 9 mg Sodium chloride, 0.278 mg Sodium phosphate, Monobasic Crystal, 1.38 mg Sodium Phosphate, Dibasic, Anhydrous, 2 mg NaN3, 0.02 g BSA